Rigel Pharmaceuticals (RIGL) Net Cash Flow (2010 - 2026)
Rigel Pharmaceuticals' quarterly Net Cash Flow came in at -$16.2 million in Q1 2026, down 47.51% year-on-year from -$30.8 million in Q1 2025, and down 103.28% quarter-over-quarter from -$8.0 million in Q4 2025.
Rigel Pharmaceuticals has reported Net Cash Flow for 17 years, with the latest figure at -$16.2 million in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 47.51% year-over-year to -$16.2 million; the trailing twelve-month figure through Mar 2026 stood at -$21.3 million (down 205.47% YoY), and the FY2025 full-year result was -$16.1 million, down 167.23% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$16.2 million, down from -$8.0 million in the prior quarter.
- The five-year high for Net Cash Flow was $15.8 million in Q1 2023, with the low at -$16.2 million in Q1 2026.
- Average Net Cash Flow over 5 years is $328117.6, with a median of $2.5 million recorded in 2022.
- Year-over-year, Net Cash Flow soared 560.24% in 2024 and plunged 257.38% in 2025.
- Tracing RIGL's Net Cash Flow over 5 years: stood at -$5.4 million in 2022, then slumped by 133.55% to -$12.6 million in 2023, then soared by 140.02% to $5.1 million in 2024, then sank by 257.38% to -$8.0 million in 2025, then slumped by 103.28% to -$16.2 million in 2026.
- The last three Net Cash Flow figures came in at -$16.2 million (Q1 2026), -$8.0 million (Q4 2025), and -$4.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.44 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 625.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.44 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 457.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -152.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 60.68 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn | -16.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.17 Mn |
| Mar 31, 2026 | -16.17 Mn |
| Dec 31, 2025 | -7.95 Mn |
| Dec 31, 2025 | -7.95 Mn |
| Sep 30, 2025 | -4.87 Mn |
| Sep 30, 2025 | -4.87 Mn |
| Jun 30, 2025 | 7.68 Mn |
| Jun 30, 2025 | 7.68 Mn |
| Mar 31, 2025 | -10.96 Mn |
| Mar 31, 2025 | -10.96 Mn |
| Dec 31, 2024 | 5.05 Mn |
| Dec 31, 2024 | 5.05 Mn |
| Sep 30, 2024 | 15.64 Mn |
| Sep 30, 2024 | 15.64 Mn |
| Jun 30, 2024 | 10.48 Mn |
| Jun 30, 2024 | 10.48 Mn |
| Mar 31, 2024 | -7.21 Mn |
| Mar 31, 2024 | -7.21 Mn |
| Dec 31, 2023 | -12.63 Mn |
| Dec 31, 2023 | -12.63 Mn |
| Sep 30, 2023 | -3.40 Mn |
| Sep 30, 2023 | -3.40 Mn |
| Jun 30, 2023 | 8.53 Mn |
| Jun 30, 2023 | 8.53 Mn |
| Mar 31, 2023 | 15.83 Mn |
| Mar 31, 2023 | 15.83 Mn |
| Dec 31, 2022 | -5.41 Mn |
| Dec 31, 2022 | -5.41 Mn |
| Sep 30, 2022 | 2.67 Mn |
| Sep 30, 2022 | 2.67 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Jun 30, 2022 | 2.52 Mn |
| Mar 31, 2022 | 5.79 Mn |
| Mar 31, 2022 | 5.79 Mn |
| Dec 31, 2021 | -11.51 Mn |
| Dec 31, 2021 | -11.51 Mn |
| Sep 30, 2021 | -54.42 Mn |
| Sep 30, 2021 | -54.42 Mn |
| Jun 30, 2021 | 64.78 Mn |
| Jun 30, 2021 | 64.78 Mn |
| Mar 31, 2021 | -10.33 Mn |
| Mar 31, 2021 | -10.33 Mn |
| Dec 31, 2020 | -6.19 Mn |
| Dec 31, 2020 | -6.19 Mn |
| Sep 30, 2020 | 98,000.00 |
| Sep 30, 2020 | 98,000.00 |
| Jun 30, 2020 | -8.76 Mn |
| Jun 30, 2020 | -8.76 Mn |
| Mar 31, 2020 | 22.70 Mn |
| Mar 31, 2020 | 22.70 Mn |
| Dec 31, 2019 | -16.57 Mn |
| Dec 31, 2019 | -16.57 Mn |
| Sep 30, 2019 | -5.14 Mn |
| Sep 30, 2019 | -5.14 Mn |
| Jun 30, 2019 | -30.47 Mn |
| Jun 30, 2019 | -30.47 Mn |
| Mar 31, 2019 | -1.63 Mn |
| Mar 31, 2019 | -1.63 Mn |
| Dec 31, 2018 | 14.84 Mn |
| Dec 31, 2018 | 14.84 Mn |
| Sep 30, 2018 | -3.59 Mn |
| Sep 30, 2018 | -3.59 Mn |
| Jun 30, 2018 | 24.95 Mn |
| Jun 30, 2018 | 24.95 Mn |
| Mar 31, 2018 | 1.84 Mn |
| Mar 31, 2018 | 1.84 Mn |
| Dec 31, 2017 | 12.41 Mn |
| Dec 31, 2017 | 12.41 Mn |
| Sep 30, 2017 | -6.71 Mn |
| Sep 30, 2017 | -6.71 Mn |
| Jun 30, 2017 | -7.55 Mn |
| Jun 30, 2017 | -7.55 Mn |
| Mar 31, 2017 | 22.51 Mn |
| Mar 31, 2017 | 22.51 Mn |
| Dec 31, 2016 | -8.32 Mn |
| Dec 31, 2016 | -8.32 Mn |
| Sep 30, 2016 | 1.00 Mn |
| Sep 30, 2016 | 1.00 Mn |
| Jun 30, 2016 | 10.68 Mn |
| Jun 30, 2016 | 10.68 Mn |
| Mar 31, 2016 | -29.19 Mn |
| Mar 31, 2016 | -29.19 Mn |
| Dec 31, 2015 | 4.88 Mn |
| Dec 31, 2015 | 4.88 Mn |
| Sep 30, 2015 | 21.29 Mn |
| Sep 30, 2015 | 21.29 Mn |
| Jun 30, 2015 | -25.43 Mn |
| Jun 30, 2015 | -25.43 Mn |
| Mar 31, 2015 | 27.52 Mn |
| Mar 31, 2015 | 27.52 Mn |
| Dec 31, 2014 | 2.39 Mn |
| Dec 31, 2014 | 2.39 Mn |
| Sep 30, 2014 | -11.07 Mn |
| Sep 30, 2014 | -11.07 Mn |
| Jun 30, 2014 | 8.97 Mn |
| Jun 30, 2014 | 8.97 Mn |
| Mar 31, 2014 | -5.94 Mn |
| Mar 31, 2014 | -5.94 Mn |
| Dec 31, 2013 | 4.82 Mn |
| Dec 31, 2013 | 4.82 Mn |
| Sep 30, 2013 | -5.84 Mn |
| Sep 30, 2013 | -5.84 Mn |
| Jun 30, 2013 | -13.11 Mn |
| Jun 30, 2013 | -13.11 Mn |
| Mar 31, 2013 | 675,000.00 |
| Mar 31, 2013 | 675,000.00 |
| Dec 31, 2012 | 6.68 Mn |
| Dec 31, 2012 | 6.68 Mn |
| Sep 30, 2012 | 650,000.00 |
| Sep 30, 2012 | 650,000.00 |
| Jun 30, 2012 | 4.12 Mn |
| Jun 30, 2012 | 4.12 Mn |
| Mar 31, 2012 | 3.40 Mn |
| Mar 31, 2012 | 3.40 Mn |
| Dec 31, 2011 | -49,000.00 |
| Dec 31, 2011 | -49,000.00 |
| Sep 30, 2011 | -24.27 Mn |
| Sep 30, 2011 | -24.27 Mn |
| Jun 30, 2011 | 17.25 Mn |
| Jun 30, 2011 | 17.25 Mn |
| Mar 31, 2011 | 16.83 Mn |
| Mar 31, 2011 | 16.83 Mn |
| Dec 31, 2010 | -13.18 Mn |
| Dec 31, 2010 | -13.18 Mn |
| Sep 30, 2010 | -10.17 Mn |
| Sep 30, 2010 | -10.17 Mn |